Folegatti P M, Ewer K J, Aley P K, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck E A, Dold C, Faust S N, Finn A, Flaxman A L, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian A M, Pollock K M, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas A D, Hill A V S, Lambe T, Gilbert S C, Pollard A J, on behalf of Oxford COVID Vaccine Trial Group (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
The Lancet 396 (10249) , 467-478
Publisher’s version: https://doi.org/10.1016/S0140-6736(20)31604-4
Pedrera M, Macchi F, McLean R K, Franceschi V, Thakur N, Russo L, Medfai L, Todd S, Tchilian E Z, Audonnet J-C, Chappell K, Isaacs A, Watterson D, Young P R, Marsh G A, Bailey D, Graham S P, Donofrio G
(2020)
Bovine herpesvirus-4-vectored delivery of Nipah virus glycoproteins enhances T cell immunogenicity in pigs
Vaccines 8 (1) , 115
Publisher’s version: https://doi.org/10.3390/vaccines8010115
Kelly J T, Human S, Alderman J, Jobe F, Logan L, Rix T, Gonçalves-Carneiro D, Leung C, Thakur N, Birch J, Bailey D
(2019)
BST2/Tetherin overexpression modulates Morbillivirus glycoprotein production to inhibit cell–cell fusion
Viruses 11 (8) , 692
Publisher’s version: https://doi.org/10.3390/v11080692
Thakur N, Bailey D (2019)
Advances in diagnostics, vaccines and therapeutics for Nipah virus
Microbes and Infection 21 (7) , 278-286
Publisher’s version: https://doi.org/10.1016/j.micinf.2019.02.002
Pages
ED&I Committee